25 related articles for article (PubMed ID: 2875475)
1. Prevalence of and risk factors for thirst in the intensive care unit: An observational study.
Lin R; Li H; Chen L; He J
J Clin Nurs; 2023 Feb; 32(3-4):465-476. PubMed ID: 35199411
[TBL] [Abstract][Full Text] [Related]
2. Opioids and Acute Kidney Injury.
Mallappallil M; Bajracharya S; Salifu M; Yap E
Semin Nephrol; 2021 Jan; 41(1):11-18. PubMed ID: 33896468
[TBL] [Abstract][Full Text] [Related]
3. Predictors of thirst in intensive care unit patients.
Stotts NA; Arai SR; Cooper BA; Nelson JE; Puntillo KA
J Pain Symptom Manage; 2015 Mar; 49(3):530-8. PubMed ID: 25116914
[TBL] [Abstract][Full Text] [Related]
4. Organic chemistry and biology: chemical biology through the eyes of collaboration.
Hruby VJ
J Org Chem; 2009 Dec; 74(24):9245-64. PubMed ID: 20000552
[TBL] [Abstract][Full Text] [Related]
5. The kappa-opioid U-50,488H suppresses the initiation of nocturnal spontaneous drinking in normally hydrated rats.
Badiani A; Stewart J
Psychopharmacology (Berl); 1992; 106(4):463-73. PubMed ID: 1315973
[TBL] [Abstract][Full Text] [Related]
6. Narcotic analgesics, their detection and pain measurement in the horse: a review.
Kamerling S; Wood T; DeQuick D; Weckman TJ; Tai C; Blake JW; Tobin T
Equine Vet J; 1989 Jan; 21(1):4-12. PubMed ID: 2563969
[TBL] [Abstract][Full Text] [Related]
7. Roles of central and peripheral mu, delta and kappa opioid receptors in the mediation of gastric acid secretory effects in the rat.
Fox DA; Burks TF
J Pharmacol Exp Ther; 1988 Feb; 244(2):456-62. PubMed ID: 2831341
[TBL] [Abstract][Full Text] [Related]
8. Mu antagonist properties of kappa agonists in a model of rat urinary bladder motility in vivo.
Sheldon RJ; Nunan L; Porreca F
J Pharmacol Exp Ther; 1987 Oct; 243(1):234-40. PubMed ID: 2822899
[TBL] [Abstract][Full Text] [Related]
9. Kappa agonists inhibit gastric emptying but not acid secretion in rhesus monkeys.
Touzeau PL; Shea-Donohue T
J Pharmacol Exp Ther; 1990 Jun; 253(3):1010-6. PubMed ID: 1972746
[TBL] [Abstract][Full Text] [Related]
10. Discriminative stimulus properties of U50,488 and morphine: effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists.
Picker MJ; Doty P; Negus SS; Mattox SR; Dykstra LA
J Pharmacol Exp Ther; 1990 Jul; 254(1):13-22. PubMed ID: 2164087
[TBL] [Abstract][Full Text] [Related]
11. Kappa opioid receptors stimulate phosphoinositide turnover in rat brain.
Periyasamy S; Hoss W
Life Sci; 1990; 47(3):219-25. PubMed ID: 1975082
[TBL] [Abstract][Full Text] [Related]
12. Centrally-administered opioid selective agonists inhibit drinking in the rat.
Spencer RL; Deupree D; Hsiao S; Mosberg HI; Hruby V; Burks TF; Porreca F
Pharmacol Biochem Behav; 1986 Jul; 25(1):77-82. PubMed ID: 2875475
[TBL] [Abstract][Full Text] [Related]
13. Endorphins and food intake: kappa opioid receptor agonists and hyperphagia.
Cooper SJ; Jackson A; Kirkham TC
Pharmacol Biochem Behav; 1985 Nov; 23(5):889-901. PubMed ID: 2867562
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
